Why the study?
Previous studies showed inconsistent results on the safety profile of antithrombotic drugs, potentially due to varying bleeding definitions and classification bias from lack of medical evaluation.
What is the risk of major haemorrhagic events associated with different antithrombotic drugs in a real-world French cohort?
Population
3 837 557 hospital visits identified in SNIIRAM linked with emergency database records
Comparison
VKA vs NOAC, antiplatelet agents, and parenteral anticoagulants
Design
Database linkage study protocol and validation
Authors
Loading...
Linking nationwide health insurance data with clinical emergency records enables more accurate categorization and medical validation of major haemorrhagic events associated with antithrombotic drugs.
What is the risk of major haemorrhagic events associated with different antithrombotic drugs in a real-world French cohort?
Linking nationwide health insurance data with clinical emergency records enables more accurate categorization and medical validation of major haemorrhagic events associated with antithrombotic drugs.
Bouget et al. (2018) studied this question.